article · Pediatric Critical Care Medicine
Aims & Objectives: Road traffic deaths (RTDs) are a major health concern worldwide, especially for children and young adults aged 5–29, with 1.35 million fatalities in 2016, mostly in low- and middle-income countries (93%). Despite child restraint systems (CRS)‘ effectiveness in reducing RTDs, their use is low, with only 33 countries adopting WHO-recommended laws. This study investigates the use of child restraint seats and risk factors for their non-use in LMICs. Methods: We analyzed cross-sectional data of CRS use from The Bloomberg Philanthropies Initiative for Global Road Safety (BIGRS) in 10 cities across Africa and Asia from 2020 to 2022. Sites were randomly selected using a standardized roadside observation collection protocol. We used a multilevel logistic regression model in Stata 18, to explain the CRS use based on individual-level predictors and accounting for random effects at the country and city levels. Results: 7,674 children under 12 years old were observed. Only 2% used CRS. Usage varied by age group: under 5 years (4%), 5-11 years (2%), and 12-17 years (16%). In multilevel regression analysis, children aged 5-11 were less likely to use CRS than those under 5 (OR 0.38, 95%CI 0.27-0.53). CRS was lower on local roads than arterial roads (OR 0.30 IC95% 0.15-0.60). 14.7% of the variability in CRS use can be explained by intra countries’ correlation, while 21% of the variability is due to correlation in cities within the same country.Conclusions: City residence, child age and road type impacts child seat use, guiding policy and fatality reduction strategies. Keywords: road traffic injuries, pediatric trauma, injuries, road safety, Child Restraint System
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1097/01.pcc.0001084760.51951.55
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.